NCT04430712View on ClinicalTrials.gov

Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume

CompletedOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

August 12, 2022

Study Completion Date

August 22, 2022

Conditions

Non-small Cell Lung Cancer

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Massachusetts General Hospital

OTHER